Atlas Trials

Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI

Clinical trial NCT05043272 · UNKNOWN

Trial details

NCT number
NCT05043272
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Covid19Overweight
Start date
2021-08-01
Primary completion
2022-05-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.